Environmental Burkholderia cepacia Complex Isolates from Human Infections
Adam Baldwin*, Eshwar Mahenthiralingam†, Pavel Drevinek†, Peter Vandamme‡, John R. Govan§, David J. Waine*, John J. LiPuma¶, Luigi Chiarini#, Claudia Dalmastri#, Deborah A. Henry**, David P. Speert**, David Honeybourne††, Martin C. J. Maiden‡‡, and Chris G. Dowson*
Author affiliations: *Warwick University, Coventry, Wales, United Kingdom; †Cardiff University, Cardiff, England, United Kingdom; ‡Universiteit Gent, Ghent, Belgium; §University of Edinburgh Medical School, Edinburgh, Scotland, United Kingdom; ¶University of Michigan Medical School, Ann Arbor, Michigan, USA; #Ente per le Nuove Tecnologie l’Energia e l’Ambiente Casaccia, Rome, Italy; **University of British Columbia, Vancouver, British Columbia, Canada; ††Birmingham Heartlands Hospital, Birmingham, England, United Kingdom; ‡‡University of Oxford, Oxford, England, United Kingdom;
Figure. Proportion of sequence types (STs) within each Burkholderia cepacia complex (Bcc) species from clinical, environmental, or both sources. The bar chart shows the proportion of STs derived from the environment (white), clinical (gray), and both sources (black shading). The total number of STs examined for each B. cepacia species is in parentheses.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.